249 related articles for article (PubMed ID: 28054978)
1. Hemoglobin-Based Blood Substitutes and the Treatment of Sickle Cell Disease: More Harm than Help?
Alayash AI
Biomolecules; 2017 Jan; 7(1):. PubMed ID: 28054978
[TBL] [Abstract][Full Text] [Related]
2. Crosslinked, polymerized, and PEG-conjugated hemoglobin-based oxygen carriers: clinical safety and efficacy of recent and current products.
Jahr JS; Akha AS; Holtby RJ
Curr Drug Discov Technol; 2012 Sep; 9(3):158-65. PubMed ID: 21745179
[TBL] [Abstract][Full Text] [Related]
3. Oxidative pathways in the sickle cell and beyond.
Alayash AI
Blood Cells Mol Dis; 2018 May; 70():78-86. PubMed ID: 28554826
[TBL] [Abstract][Full Text] [Related]
4. HBOC-201 vasoactivity in a phase III clinical trial in orthopedic surgery subjects--extrapolation of potential risk for acute trauma trials.
Freilich D; Pearce LB; Pitman A; Greenburg G; Berzins M; Bebris L; Ahlers S; McCarron R
J Trauma; 2009 Feb; 66(2):365-76. PubMed ID: 19204509
[TBL] [Abstract][Full Text] [Related]
5. Blood substitutes and oxygen therapeutics: an overview and current status.
Jahr JS; Nesargi SB; Lewis K; Johnson C
Am J Ther; 2002; 9(5):437-43. PubMed ID: 12237737
[TBL] [Abstract][Full Text] [Related]
6. All hemoglobin-based oxygen carriers are not created equally.
Buehler PW; Alayash AI
Biochim Biophys Acta; 2008 Oct; 1784(10):1378-81. PubMed ID: 18206989
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Biochemical and Biophysical Characterization of Hemoglobin-Based Oxygen Carrier Therapeutics: All HBOCs Are Not Created Equally.
Meng F; Kassa T; Jana S; Wood F; Zhang X; Jia Y; D'Agnillo F; Alayash AI
Bioconjug Chem; 2018 May; 29(5):1560-1575. PubMed ID: 29570272
[TBL] [Abstract][Full Text] [Related]
8. Hemoglobin-based oxygen carriers: From mechanisms of toxicity and clearance to rational drug design.
Buehler PW; D'Agnillo F; Schaer DJ
Trends Mol Med; 2010 Oct; 16(10):447-57. PubMed ID: 20708968
[TBL] [Abstract][Full Text] [Related]
9. Use of the blood substitute HBOC-201 in critically ill patients during sickle crisis: a three-case series.
Davis JM; El-Haj N; Shah NN; Schwartz G; Block M; Wall J; Tidswell M; DiNino E
Transfusion; 2018 Jan; 58(1):132-137. PubMed ID: 29076161
[TBL] [Abstract][Full Text] [Related]
10. Hemoglobin-Based Oxygen Carrier (HBOC) Development in Trauma: Previous Regulatory Challenges, Lessons Learned, and a Path Forward.
Keipert PE
Adv Exp Med Biol; 2017; 977():343-350. PubMed ID: 28685464
[TBL] [Abstract][Full Text] [Related]
11. From hemoglobin allostery to hemoglobin-based oxygen carriers.
Faggiano S; Ronda L; Bruno S; Abbruzzetti S; Viappiani C; Bettati S; Mozzarelli A
Mol Aspects Med; 2022 Apr; 84():101050. PubMed ID: 34776270
[TBL] [Abstract][Full Text] [Related]
12. A phase I/II study of polymerized bovine hemoglobin in adult patients with sickle cell disease not in crisis at the time of study.
Gonzalez P; Hackney AC; Jones S; Strayhorn D; Hoffman EB; Hughes G; Jacobs EE; Orringer EP
J Investig Med; 1997 Jun; 45(5):258-64. PubMed ID: 9249998
[TBL] [Abstract][Full Text] [Related]
13. HBOC-201, hemoglobin glutamer-250 (bovine), Hemopure (Biopure Corporation).
Jahr JS; Moallempour M; Lim JC
Expert Opin Biol Ther; 2008 Sep; 8(9):1425-33. PubMed ID: 18694360
[TBL] [Abstract][Full Text] [Related]
14. Artificial oxygen carrier with pharmacologic actions of adenosine-5'-triphosphate, adenosine, and reduced glutathione formulated to treat an array of medical conditions.
Simoni J; Simoni G; Moeller JF; Feola M; Wesson DE
Artif Organs; 2014 Aug; 38(8):684-90. PubMed ID: 24980041
[TBL] [Abstract][Full Text] [Related]
15. High- and low-affinity PEGylated hemoglobin-based oxygen carriers: Differential oxidative stress in a Guinea pig transfusion model.
Alomari E; Ronda L; Bruno S; Paredi G; Marchetti M; Bettati S; Olivari D; Fumagalli F; Novelli D; Ristagno G; Latini R; Cooper CE; Reeder BJ; Mozzarelli A
Free Radic Biol Med; 2018 Aug; 124():299-310. PubMed ID: 29920341
[TBL] [Abstract][Full Text] [Related]
16. SANGUINATE (PEGylated Carboxyhemoglobin Bovine): Mechanism of Action and Clinical Update.
Abuchowski A
Artif Organs; 2017 Apr; 41(4):346-350. PubMed ID: 28397407
[TBL] [Abstract][Full Text] [Related]
17. Hemoglobin substitutes.
Anbari KK; Garino JP; Mackenzie CF
Eur Spine J; 2004 Oct; 13 Suppl 1(Suppl 1):S76-82. PubMed ID: 15168238
[TBL] [Abstract][Full Text] [Related]
18. Hemoglobin-based oxygen carriers for hemorrhagic shock.
Elmer J; Alam HB; Wilcox SR
Resuscitation; 2012 Mar; 83(3):285-92. PubMed ID: 21978876
[TBL] [Abstract][Full Text] [Related]
19. Potential uses of hemoglobin-based oxygen carriers in critical care medicine.
Creteur J; Vincent JL
Crit Care Clin; 2009 Apr; 25(2):311-24, Table of Contents. PubMed ID: 19341911
[TBL] [Abstract][Full Text] [Related]
20. [Hemoglobin-based oxygen carriers and trials to substitute red blood cells].
Smani Y; Labrude P; Vigneron C; Faivre B
Transfus Clin Biol; 2007 Nov; 14(5):464-73. PubMed ID: 18295525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
